Early Differential Changes in Coronary Plaque Composition According to Plaque Stability Following Statin Initiation in Acute Coronary Syndrome: Classification and Analysis by Intravascular Ultrasound-Virtual Histology
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to demonstrate the early effects of statin treatment on plaque composition according to plaque stability on Intravascular Ultrasound-Virtual Histology at 6 months after a coronary event. Previous trials have demonstrated that lipid lowering therapy with statins decreases plaque volume and increases plaque echogenicity in patients with coronary artery disease. Materials and Methods: Fifty-four patients (54 lesions) with acute coronary syndrome were prospectively enrolled. We classified and analyzed the target plaques into two types according to plaque stability: thin-cap fibroatheroma (TCFA, n=14) and non-TCFA (n=40). The primary end point was change in percent necrotic core in the 10-mm subsegment with the most disease. Results: After 6 months of statin therapy, no change was demonstrated in the mean percentage of necrotic core (18.7±8.5% to 20.0±11.0%, p=0.38). There was a significant reduction in necrotic core percentage in patients with TCFA (21.3±7.2% to 14.4±8.9%, p=0.017), but not in patients with non-TCFA. Moreover, change in percent necrotic core was significantly correlated with change in high-sensitivity C-reactive protein levels (r=0.4, p=0.003). Changes in low-density lipoprotein cholesterol levels and lipid core percentage demonstrated no significant associations. Conclusion: A clear reduction of lipid core was observed only for the TCFA plaque type, suggesting that changes in plaque composition following statin therapy might occur earlier in vulnerable plaque than in stable plaque; the effect may be related to the anti-inflammatory effects of statins.
Abstract
Purpose: The aim of this study was to demonstrate the early effects of statin treatment on plaque composition according to plaque stability on Intravascular Ultrasound-Virtual Histology at 6 months after a coronary event. Previous trials have demonstrated that lipid lowering therapy with statins decreases plaque volume and increases plaque echogenicity in patients with coronary artery disease. Materials and Methods: Fifty-four patients (54 lesions) with acute coronary syndrome were prospectively enrolled. We classified and analyzed the target plaques into two types according to plaque stability: thin-cap fibroatheroma (TCFA, n=14) and non-TCFA (n=40). The primary end point was change in percent necrotic core in the 10-mm subsegment with the most disease. Results: After 6 months of statin therapy, no change was demonstrated in the mean percentage of necrotic core (18.7±8.5% to 20.0±11.0%, p=0.38). There was a significant reduction in necrotic core percentage in patients with TCFA (21.3±7.2% to 14.4±8.9%, p=0.017), but not in patients with non-TCFA. Moreover, change in percent necrotic core was significantly correlated with change in high-sensitivity C-reactive protein levels (r=0.4, p=0.003). Changes in low-density lipoprotein cholesterol levels and lipid core percentage demonstrated no significant associations. Conclusion: A clear reduction of lipid core was observed only for the TCFA plaque type, suggesting that changes in plaque composition following statin therapy might occur earlier in vulnerable plaque than in stable plaque; the effect may be related to the anti-inflammatory effects of statins.
참고문헌 (23)
- Virmani R, "Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions", Arterioscler Thromb Vasc Biol, 20, pp.1262~1275 (2000)
- Davies MJ, "Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content", Br Heart J, 69, pp.377~381 (1993)
- Nair A, "Coronary plaque classification with intravascular ultrasound radiofrequency data analysis", Circulation, 106, pp.2200~2206 (2002)
- Rodriguez-Granillo GA, "In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis", J Am Coll Cardiol, 46, pp.2038~2042 (2005)
- Nasu K, "Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology", J Am Coll Cardiol, 47, pp.2405~2412 (2006)
- "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)", Lancet, 344, pp.1383~1389 (1994)
- Heart Protection Study Collaborative Group, "MRC", BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, 2002, pp.360, 7~22
- "Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators", Lancet, 354, pp.708~715 (1999)
- Schwartz GG, "Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial", JAMA, 285, pp.1711~1718 (2001)
- Cannon CP, "Intensive versus moderate lipid lowering with statins after acute coronary syndromes", N Engl J Med, 350, pp.1495~1504 (2004)
- Okazaki S, "Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study", Circulation, 110, pp.1061~1068 (2004)
- Goldstein JA, "Multiple complex coronary plaques in patients with acute myocardial infarction", N Engl J Med, 343, pp.915~922 (2000)
- Lee SG, "Change of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography", Am Heart J, 147, pp.281~286 (2004)
- Ridker PM, "C-reactive protein levels and outcomes after statin therapy", N Engl J Med, 352, pp.20~28 (2005)
- Newby LK, "Early statin initiation and outcomes in patients with acute coronary syndromes", JAMA, 287, pp.3087~3095 (2002)
- Nissen SE, "Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial", JAMA, 291, pp.1071~1080 (2004)
- Nissen SE, "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial", JAMA, 295, pp.1556~1565 (2006)
- Schartl M, "Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease", Circulation, 104, pp.387~392 (2001)
- Kawasaki M, "Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound", J Am Coll Cardiol, 45, pp.1946~1953 (2005)
- Armstrong ML, "Arterial fibrous proteins in cynomolgus monkeys after atherogenic and regression diets", Circ Res, 36, pp.256~261 (1975)
- Aikawa M, "Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization", Circulation, 97, pp.2433~2444 (1998)
- Schoenhagen P, "Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial", Circulation, 113, pp.2826~2834 (2006)
- Sawada T, "Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma", Eur Heart J, 29, pp.1136~1146 (2008)